Home
About Us
Team
Science
Pipelines
Investor Relations
Contact
More
GlobeNewswire
10/22/25
Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement
9/12/25
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters
8/27/25
Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering
U.S. Securities and Exchange Commission
8/26/25
Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering
